Jade Biosciences, Inc. (JBIO) Misses Q2 EPS by 55c

Jade Biosciences, Inc. (NASDAQ: JBIO) reported Q2 EPS of ($0.86), $0.55 worse than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Jade Biosciences, Inc. (JBIO) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Paramount Skydance, Warner Bros spiking higher on volume
• Compass Diversified (CODI)7500 contracts of December 13 calls trade